'Knockoff' Blood Clot Product Still On Market: Supplement Co.

Law360, New York (March 11, 2013, 7:47 PM EDT) -- Daniels Health Sciences LLC asked a Texas federal court on Monday to hold Vascular Health Sciences LLC in contempt for not complying with a preliminary injunction blocking it from marketing or selling a purported knockoff version of Daniels’ arterial blood clot reduction supplement Provasca.

As of early Monday, Daniels Health said Vascular was still selling and marketing its version of the dietary supplement, called Arterosil, even after the Fifth Circuit upheld the injunction on March 5 in light of available evidence that Vascular allegedly misappropriated trade...
To view the full article, register now.




Case Information

Case Title

Daniels Health Sciences, LLC v. Vascular Health Sciences, LLC

Case Number



Texas Southern

Nature of Suit



Judge Kenneth M. Hoyt

Date Filed

June 25, 2012

Law Firms

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.